Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study.

BACKGROUND Cognitive status in females with mutations in the FMR1 (fragile X mental retardation 1) gene is highly variable. A biomarker would be of value for predicting which individuals were liable to develop cognitive impairment and could benefit from early intervention. A detailed analysis of CpG sites bridging exon 1 and intron 1 of FMR1, known as fragile X-related epigenetic element 2 (FREE2), suggests that a simple blood test could identify these individuals. METHODS Study participants included 74 control females (<40 CGG repeats), 62 premutation (PM) females (55-200 CGG repeats), and 18 full-mutation (FM) females assessed with Wechsler intelligence quotient (IQ) tests. We used MALDI-TOF mass spectrometry to determine the methylation status of FREE2 CpG sites that best identified low-functioning (IQ <70) FM females (>200 CGG repeats), compared the results with those for Southern blot FMR1 activation ratios, and related these assessments to the level of production of the FMR1 protein product in blood. RESULTS A methylation analysis of intron 1 CpG sites 10-12 showed the highest diagnostic sensitivity (100%) and specificity (98%) of all the molecular measures tested for detecting females with a standardized verbal IQ of <70 among the study participants. In the group consisting of only FM females, methylation of these sites was significantly correlated with full-scale IQ, verbal IQ, and performance IQ. Several verbal subtest scores showed strong correlation with the methylation of these sites (P = 1.2 × 10(-5)) after adjustment for multiple measures. CONCLUSIONS The data suggest that hypermethylation of the FMR1 intron 1 sites in blood is predictive of cognitive impairment in FM females, with implications for improved fragile X syndrome diagnostics in young children and screening of the newborn population.

[1]  Kurt Hornik,et al.  The Comprehensive R Archive Network , 2012 .

[2]  D. Loesch,et al.  FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. , 2011, The Journal of molecular diagnostics : JMD.

[3]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[4]  D. Loesch,et al.  Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism , 2011, Genetics in Medicine.

[5]  Allen D. Delaney,et al.  Conserved Role of Intragenic DNA Methylation in Regulating Alternative Promoters , 2010, Nature.

[6]  L. Doherty,et al.  Bisphenol‐A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  Oliver Kaut,et al.  Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' Brains , 2010, The Journal of Neuroscience.

[8]  E. Sekinger,et al.  A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. , 2010, Clinical chemistry.

[9]  D. Loesch,et al.  Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. , 2010, Human molecular genetics.

[10]  J. Mowrey,et al.  Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. , 2009, American journal of human genetics.

[11]  Randi J. Hagerman,et al.  Advances in the Treatment of Fragile X Syndrome , 2009, Pediatrics.

[12]  A. Nygren,et al.  Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles. , 2008, The Journal of molecular diagnostics : JMD.

[13]  John O. Willis,et al.  Wechsler Adult Intelligence Scale–Third Edition , 2008 .

[14]  M. Khaniani,et al.  An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1) , 2008, Molecular Cytogenetics.

[15]  D. Loesch,et al.  Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X , 2007, Neuroscience & Biobehavioral Reviews.

[16]  S. Clark,et al.  Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements , 2007, Nucleic acids research.

[17]  G. Spiridigliozzi,et al.  Arithmetic difficulties in females with the fragile X premutation , 2006, American journal of medical genetics. Part A.

[18]  W. Robinson,et al.  FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure , 2005, Human Genetics.

[19]  M. Epstein,et al.  Association of FMR1 repeat size with ovarian dysfunction. , 2005, Human reproduction.

[20]  B. Oostra,et al.  Molecular dissection of the events leading to inactivation of the FMR1 gene. , 2005, Human molecular genetics.

[21]  C. Boehm,et al.  Robust fragile X (CGG)n genotype classification using a methylation specific triple PCR assay , 2004, Journal of Medical Genetics.

[22]  D. Loesch,et al.  Effect of fragile X status categories and FMRP deficits on cognitive profiles estimated by robust pedigree analysis , 2003, American journal of medical genetics. Part A.

[23]  D. Loesch,et al.  Effect of the Deficits of Fragile X Mental Retardation Protein on Cognitive Status of Fragile X Males and Females Assessed by Robust Pedigree Analysis , 2002, Journal of developmental and behavioral pediatrics : JDBP.

[24]  B. Oostra,et al.  Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. , 2002, Nucleic acids research.

[25]  A. Lammert,et al.  A Rapid, Quantitative Immunofunctional Assay for Measuring Human Leptin , 2002, Hormone Research in Paediatrics.

[26]  D. Loesch,et al.  Application of robust pedigree analysis in studies of complex genotype-phenotype relationships in fragile X syndrome. , 2002, American journal of medical genetics.

[27]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[28]  W. Greenough,et al.  Dendritic spine structural anomalies in fragile-X mental retardation syndrome. , 2000, Cerebral cortex.

[29]  P. Hagerman,et al.  Transcription of the FMR1 gene in individuals with fragile X syndrome. , 2000, American journal of medical genetics.

[30]  P. Jin,et al.  Understanding the molecular basis of fragile X syndrome. , 2000, Human molecular genetics.

[31]  B. Oostra,et al.  FMRP expression as a potential prognostic indicator in fragile X syndrome. , 1999, American journal of medical genetics.

[32]  A. Reiss,et al.  Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome. , 1999, American journal of medical genetics.

[33]  B. D. de Vries,et al.  Mental status of females with an FMR1 gene full mutation. , 1996, American journal of human genetics.

[34]  S. Thibodeau,et al.  High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. , 1994, American journal of medical genetics.

[35]  K. A. Lang,et al.  Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. , 1994, JAMA.

[36]  D. Nelson,et al.  High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. , 1993, Human molecular genetics.

[37]  J. Mandel,et al.  Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. , 1992, American journal of medical genetics.

[38]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[39]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[40]  D. Munoz.  Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. , 2002, Neurology.

[41]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[42]  H. D. Peters.  The Wechsler Intelligence Scale for Children Revised: A Review. , 1975 .

[43]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.